Enterocytic CYP3A4 in a paediatric population: Developmental changes and the effect of coeliac disease and cystic fibrosis

British Journal of Clinical Pharmacology

Volumn 51, Issue 5, 2001, Pages 451-460

  Johnson, Trevor N ^a   Tanner, M Stuart ^a   Taylor, Christopher J ^a   Tucker, Geoffrey T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Children; Coeliac disease; CYP3A4; Cystic fibrosis; Duodenum; Fetus; Intestine; Paediatrics

Indexed keywords

6BETA HYDROXYTESTOSTERONE; CELL MARKER; CYTOCHROME P450 3A4; INTESTINE ENZYME; TESTOSTERONE; UNCLASSIFIED DRUG; VILLIN;

ADOLESCENT; AGE; ARTICLE; BIOAVAILABILITY; CELIAC DISEASE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; DUODENUM BIOPSY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INTESTINE CELL; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADOLESCENT; AGE FACTORS; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; INTESTINES; MALE; MIXED FUNCTION OXYGENASES;

EID: 0034843270     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.01370.x     Document Type: Article

References (45)

1. Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species
2. Extrahepatic metabolism of drugs in humans
3. Identification of glucocorticoid-inducible cytochrome P450 in the intestinal mucosa of rats and man
4. Characterisation of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism
5. Overlapping substrate specificities and tissue distribution of cytochrome P4503A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
6. The barrier function of CYP3A4 and P-glycoprotein in the small bowel
7. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporin
8. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin
9. Interaction between grapefruit juice and midazolam in humans
10. Aflatoxin B1-adduct formation in rat and human small bowel enterocytes
11. Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavenoids
12. Celiac disease and malignancy
13. Effects of chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers
14. The intestinal enzymatic biotransformation system: Potential role in protection from colon cancer
15. Ontogeny of enterocytic and hepatic cytochrome P4503A in the rat
16. Cytochrome P4503A ontogeny and drug disposition
17. The expression of xenobiotic metabolizing cytochrome P450 in fetal tissues
18. Expression of CYP3A in the human liver. Evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth
19. CYP3A gene expression in human gut epithelium
20. Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue
21. Cytochromes P-450 in the intestinal mucosa of man
22. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: Lack of prediction by the erythromycin breath test
23. Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P450 enzyme
24. Characterisation of dextromethorphan N-demethylation by human liver microsomes: Contribution of the cytochrome P450, 3A subfamily
25. Identification of a polymorphically expressed member of the human cytochrome P450 III family
26. Characterization of human small intestinal cytochromes P-450
27. Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells?
28. Differential localization of villin and fibrin during development of the mouse visceral endoderm and intestinal epithelium
29. Developmental pattern of glucose-6-phosphatase activity in the small intestine of the mouse fetus
30. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis Menton model
31. Decreased intestinal CYP3A in celiac disease: Reversal after successful gluten-free diet: A potential source of interindividual variability in first pass drug metabolism
32. Disorders of the alimentary tract and liver
33. Oral first pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism
34. The pharmacokinetics of midazolam in man
35. The pharmacokinetics of midazolam in paediatric patients
36. Differentiation of absorption and first pass gut and hepatic metabolism in humans: Studies with cyclosporin
37. Oral cyclosporin A pharmacokinetics in paediatric renal and liver transplant recipients
38. Carbamazepine clearance in paediatric epilepsy patients
39. The metabolization of carbamazepine to CBZ-10,11-epoxide in children from the newborn age to adolescence
40. Drug absorption in gastrointestinal disease and surgery
41. Absorption of propranolol and practolol in coeliac disease
42. Altered jejunal surface pH in coeliac disease: Its effects on propranolol and folic acid absorption
43. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease
44. Propranolol absorption in untreated coeliac disease
45. Drug disposition in cystic fibrosis